Table 2.
Adverse events | All grades (%) | Grade 1 (%) | Grade 2 (%) | Grade 3 (%) | Grade 4 (%) |
---|---|---|---|---|---|
Hypertension | 71 | 19 | 26 | 26 | 0 |
Decreased weight | 70 | 30 | 33 | 7 | 0 |
Fatigue | 59 | 33 | 26 | 0 | 0 |
Proteinuria | 48 | 29 | 19 | 0 | 0 |
Diarrhea | 44 | 26 | 9 | 7 | 2 |
Decreased appetite | 23 | 14 | 9 | 0 | 0 |
Asthenia | 21 | 19 | 2 | 0 | 0 |
Palmar-plantar erythrodysesthesia syndrome | 14 | 12 | 0 | 2 | 0 |
Electrolyte derailment | 14 | 12 | 2 | 0 | 0 |
Vomiting | 7 | 7 | 0 | 0 | 0 |
QT-prolongation | 5 | 5 | 0 | 0 | 0 |
Mouth dryness | 5 | 5 | 0 | 0 | 0 |
Liver dysfunction | 2 | 0 | 2 | 0 | 0 |